Global practices of meningococcal vaccine use and impact on invasive disease.
about
N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory NetworkImmunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialEstimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine IntroductionDistribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisationUse of cerebrospinal fluid and serum samples impregnated on FTATM Elute filter paper for the diagnosis of infections caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzaeComplement inhibition as potential new therapy for antibody-mediated rejection.Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.Challenges and opportunities for Meningococcal vaccination in the developing world.A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.A protocol for a systematic review of the diagnostic accuracy of Loop-mediated-isothermal AMPlification (LAMP) in diagnosis of invasive meningococcal disease in children.
P2860
Q26744800-F2F59934-056A-461E-A5A1-5F8F72AB2940Q28650557-724DA875-F930-4298-BF41-0039FB3134E3Q36006680-DD50A499-E3D9-4C28-8BD3-560265F1AABDQ36103475-B168604F-9C25-479E-9C0C-76B422FDD307Q36290206-BC2C3193-C2D7-437C-8024-D8032A643F2CQ38609238-8A495BA8-F972-4D63-82F9-A672E4B34D39Q38631381-EDBA06F8-BBBC-4D76-9D9C-A93954BFC01FQ38931495-233EF40B-E556-4F08-AD30-C534FF962D64Q40268050-7175BA49-6700-4CB1-89F7-43CBC7333583Q40287241-8968B9A9-F1BF-4B35-8B1B-064932B5D28FQ47553316-5671C820-BAD9-4F50-BCF1-B2E0AEB7DD15Q47557070-5C04FB09-584B-4DC4-9D26-B0D3AC3C7FEBQ49377063-A804C73C-E12C-46F0-ADD5-03EB8A63BFB5Q51783585-BE0C5000-4307-47F3-9E23-8EFE92F643C8Q55472702-F580978F-E0E4-4646-B32B-FA127E30CEE1
P2860
Global practices of meningococcal vaccine use and impact on invasive disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Global practices of meningococcal vaccine use and impact on invasive disease.
@ast
Global practices of meningococcal vaccine use and impact on invasive disease.
@en
type
label
Global practices of meningococcal vaccine use and impact on invasive disease.
@ast
Global practices of meningococcal vaccine use and impact on invasive disease.
@en
prefLabel
Global practices of meningococcal vaccine use and impact on invasive disease.
@ast
Global practices of meningococcal vaccine use and impact on invasive disease.
@en
P2093
P2860
P50
P1476
Global practices of meningococcal vaccine use and impact on invasive disease.
@en
P2093
Carol Tevi-Benissan
David Durrheim
Florence Fermon
Jon Abramson
Juhani Eskola
Mary Ramsay
Rabab Zehra Jafri
Shao Zhujun
P2860
P356
10.1179/2047773214Y.0000000126
P577
2014-01-01T00:00:00Z